Daniel F. Lewandowski

Daniel Lewandowski practices at Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health.

Daniel Lewandowski's NPI, 1063072163, was assigned on June 19, 2019. Daniel Lewandowski holds Michigan license 4301508254.

Daniel Lewandowski's primary practice is Henry Ford Hospital, at 2799 W Grand Blvd, Detroit, MI 48202 in Wayne County. The practice phone is (313) 916-2600.

Daniel Lewandowski's primary practice is Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health. The medical group on file is Henry Ford Health. Dmand AI also links Daniel Lewandowski to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Daniel Lewandowski practices. Vendor and product names are available with a free account.

Emergency medicine is Daniel Lewandowski's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Daniel Lewandowski is licensed in Michigan.

CMS data shows 61 Medicare services from Daniel Lewandowski across 3 procedure codes in 2024, for 64 Medicare patients. Medicare paid $6,028 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 64 Medicare patients who saw Daniel Lewandowski in 2024. The largest group is 65 to 74, with 27 patients. 73% of them have high blood pressure, and 56% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Daniel Lewandowski's median patient age at 60, with 57% women.

In 2024, Daniel Lewandowski wrote 85 Medicare Part D claims for 62 patients. 95% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $107 in total drug cost.

Daniel Lewandowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Daniel Lewandowski from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Edwards Lifesciences Corporation paid the most, $40.